Similar articles

Abstract: Global DNA hypomethylation has been associated with increased risk for cancers of the colorectum, bladder, breast, head and neck, and testicular germ cells. The aim of this study was to examine whether global hypomethylation in blood leukocyte DNA is associated with the risk of hepatocellular carcinoma (HCC). A total of 315 HCC cases and 356 age-, sex- and HBsAg status-matched controls were included. Global methylation in blood leukocyte DNA was estimated by analyzing long interspersed element-1 (LINE-1) repeats using bisulfite-polymerase chain reaction (PCR) and pyrosequencing. We observed that the median methylation level in HCC cases (percentage of 5-methylcytosine (5mC)=77.7%) was significantly lower than that in controls (79.5% 5mC) (P=0.004, Wilcoxon rank-sum test). The odds ratios (ORs) of HCC for individuals in the third, second, and first (lowest) quartiles of LINE-1 methylation were 1.1 (95% confidence interval (CI) 0.7–1.8), 1.4 (95% CI 0.8–2.2), and 2.6 (95% CI 1.7–4.1) (P for trend <0.001), respectively, compared to individuals in the fourth (highest) quartile. A 1.9-fold (95% CI 1.4–2.6) increased risk of HCC was observed among individuals with LINE-1 methylation below the median compared to individuals with higher (>median) LINE-1 methylation. Our results demonstrate for the first time that individuals with global hypomethylation measured in LINE-1 repeats in blood leukocyte DNA have an increased risk for HCC. Our data provide the evidence that global hypomethylation detected in the easily obtainable DNA source of blood leukocytes may help identify individuals at risk of HCC.

[1]Bjornsson, H.T., Fallin, M.D., Feinberg, A.P., 2004. An integrated epigenetic and genetic approach to common human disease. Trends Genet., 20(8):350-358.

[2]Bjornsson, H.T., Sigurdsson, M.I., Fallin, M.D., Irizarry, R.A., Aspelund, T., Cui, H., Yu, W., Rongione, M.A., Ekstrom, T.J., Harris, T.B., et al., 2008. Intra-individual change over time in DNA methylation with familial clustering. JAMA, 299(24):2877-2883.

[3]Bollati, V., Baccarelli, A., Hou, L., Bonzini, M., Fustinoni, S., Cavallo, D., Byun, H.M., Jiang, J., Marinelli, B., Pesatori, A.C., et al., 2007. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res., 67(3):876-880.

[4]Breton, C.V., Byun, H.M., Wenten, M., Pan, F., Yang, A., Gilliland, F.D., 2009. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am. J. Respir. Crit. Care Med., 180(5):462-467.

[5]Burden, A.F., Manley, N.C., Clark, A.D., Gartler, S.M., Laird, C.D., Hansen, R.S., 2005. Hemimethylation and non-CpG methylation levels in a promoter region of human LINE-1 (L1) repeated elements. J. Biol. Chem., 280(15):14413-14419.

[6]Cho, N.Y., Kim, B.H., Choi, M., Yoo, E.J., Moon, K.C., Cho, Y.M., Kim, D., Kang, G.H., 2007. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. J. Pathol., 211(3):269-277.

[7]Cho, Y.H., Yazici, H., Wu, H.C., Terry, M.B., Gonzalez, K., Qu, M., Dalay, N., Santella, R.M., 2010. Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. Anticancer Res., 30(7):2489-2496.

[8]Choi, J.Y., James, S.R., Link, P.A., McCann, S.E., Hong, C.C., Davis, W., Nesline, M.K., Ambrosone, C.B., Karpf, A.R., 2009. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis, 30(11):1889-1897.

[9]Cordaux, R., Batzer, M.A., 2009. The impact of retrotransposons on human genome evolution. Nat. Rev. Genet., 10(10):691-703.

[10]Das, P.M., Singal, R., 2004. DNA methylation and cancer. J. Clin. Oncol., 22(22):4632-4642.

[11]El-Maarri, O., Becker, T., Junen, J., Manzoor, S.S., Diaz-Lacava, A., Schwaab, R., Wienker, T., Oldenburg, J., 2007. Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum. Genet., 122(5):505-514.

[12]Feinberg, A.P., Tycko, B., 2004. The history of cancer epigenetics. Nat. Rev. Cancer, 4(2):143-153.

[13]Feinberg, A.P., Ohlsson, R., Henikoff, S., 2006. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet., 7(1):21-33.

[14]Formeister, E.J., Tsuchiya, M., Fujii, H., Shpyleva, S., Pogribny, I.P., Rusyn, I., 2010. Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma. Mutat. Res., 692(1-2):26-33.

[15]Gaudet, F., Hodgson, J.G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J.W., Leonhardt, H., Jaenisch, R., 2003. Induction of tumors in mice by genomic hypomethylation. Science, 300(5618):489-492.

[16]Gluckman, P.D., Hanson, M.A., Cooper, C., Thornburg, K.L., 2008. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med., 359(1):61-73.

[17]Gomaa, A.I., Khan, S.A., Toledano, M.B., Waked, I., Taylor-Robinson, S.D., 2008. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J. Gastroenterol., 14(27):4300-4308.

[18]Hillemacher, T., Frieling, H., Moskau, S., Muschler, M.A., Semmler, A., Kornhuber, J., Klockgether, T., Bleich, S., Linnebank, M., 2008. Global DNA methylation is influenced by smoking behaviour. Eur. Neuropsychopharmacol., 18(4):295-298.

[19]Hsieh, C.L., 2000. Dynamics of DNA methylation pattern. Curr. Opin. Genet. Dev., 10(2):224-228.

[20]Hsiung, D.T., Marsit, C.J., Houseman, E.A., Eddy, K., Furniss, C.S., McClean, M.D., Kelsey, K.T., 2007. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 16(1):108-114.

[21]Iskow, R.C., McCabe, M.T., Mills, R.E., Torene, S., Pittard, W.S., Neuwald, A.F., van Meir, E.G., Vertino, P.M., Devine, S.E., 2010. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell, 141(7):1253-1261.

[22]Kim, Y.J., Lee, H.S., 2005. Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Intervirology, 48(1):10-15.

[23]Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W., et al., 2001. Initial sequencing and analysis of the human genome. Nature, 409(6822):860-921.

[24]Lee, H.S., Kim, B.H., Cho, N.Y., Yoo, E.J., Choi, M., Shin, S.H., Jang, J.J., Suh, K.S., Kim, Y.S., Kang, G.H., 2009. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma. Clin. Cancer Res., 15(3):812-820.

[25]Lei, H.J., Chau, G.Y., Lui, W.Y., Tsay, S.H., King, K.L., Loong, C.C., Wu, C.W., 2006. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J. Am. Coll. Surg., 203(4):426-435.

[26]Lim, U., Flood, A., Choi, S.W., Albanes, D., Cross, A.J., Schatzkin, A., Sinha, R., Katki, H.A., Cash, B., Schoenfeld, P., et al., 2008. Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. Gastroenterology, 134(1):47-55.

[27]Liu, F., Killian, J.K., Yang, M., Walker, R.L., Hong, J.A., Zhang, M., Davis, S., Zhang, Y., Hussain, M., Xi, S., et al., 2010. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene, 29(25):3650-3664.

[28]Mirabello, L., Savage, S.A., Korde, L., Gadalla, S.M., Greene, M.H., 2010. LINE-1 methylation is inherited in familial testicular cancer kindreds. BMC Med. Genet., 11(1):77.

[29]Moore, L.E., Pfeiffer, R.M., Poscablo, C., Real, F.X., Kogevinas, M., Silverman, D., Garcia-Closas, R., Chanock, S., Tardon, A., Serra, C., et al., 2008. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish bladder cancer study: a case-control study. Lancet Oncol., 9(4):359-366.

[30]Morgan, T.R., Mandayam, S., Jamal, M.M., 2004. Alcohol and hepatocellular carcinoma. Gastroenterology, 127(5):S87-S96.

[31]Ogino, S., Kawasaki, T., Nosho, K., Ohnishi, M., Suemoto, Y., Kirkner, G.J., Fuchs, C.S., 2008. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int. J. Cancer, 122(12):2767-2773.

[32]Okuda, H., 2007. Hepatocellular carcinoma development in cirrhosis. Best Pract. Res. Clin. Gastroenterol., 21(1):161-173.

[33]Parkin, D.M., Bray, F., Ferlay, J., Pisani, P., 2005. Global cancer statistics, 2002. CA Cancer J. Clin., 55(2):74-108.

[34]Pufulete, M., Al-Ghnaniem, R., Leather, A.J., Appleby, P., Gout, S., Terry, C., Emery, P.W., Sanders, T.A., 2003. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology, 124(5):1240-1248.

[35]Rusiecki, J.A., Baccarelli, A., Bollati, V., Tarantini, L., Moore, L.E., Bonefeld-Jorgensen, E.C., 2008. Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit. Environ. Health Perspect., 116(11):1547-1552.

[36]Schernhammer, E.S., Giovannucci, E., Kawasaki, T., Rosner, B., Fuchs, C.S., Ogino, S., 2010. Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut, 59(6):794-799.

[37]Shariff, M.I., Cox, I.J., Gomaa, A.I., Khan, S.A., Gedroyc, W., Taylor-Robinson, S.D., 2009. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev. Gastroenterol. Hepatol., 3(4):353-367.

[38]Suzuki, H., Toyota, M., Sato, H., Sonoda, T., Sakauchi, F., Mori, M., 2006. Roles and causes of abnormal DNA methylation in gastrointestinal cancers. Asian Pac. J. Cancer Prev., 7(2):177-185.

[39]Tangkijvanich, P., Hourpai, N., Rattanatanyong, P., Wisedopas, N., Mahachai, V., Mutirangura, A., 2007. Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma. Clin. Chim. Acta, 379(1-2):127-133.

[40]Tarantini, L., Bonzini, M., Apostoli, P., Pegoraro, V., Bollati, V., Marinelli, B., Cantone, L., Rizzo, G., Hou, L., Schwartz, J., et al., 2009. Effects of particulate matter on genomic DNA methylation content and iNOS promoter methylation. Environ. Health Perspect., 117(2):217-222.

[41]Thomas, G.A., Williams, E.D., 1992. Production of thyroid tumours in mice by demethylating agents. Carcinogenesis, 13(6):1039-1042.

[42]Wan, Y.J., Li, Y.Y., Xia, W., Chen, J., Lv, Z.Q., Zeng, H.C., Zhang, L., Yang, W.J., Chen, T., Lin, Y., et al., 2010. Alterations in tumor biomarker GSTP gene methylation patterns induced by prenatal exposure to PFOS. Toxicology, 274(1-3):57-64.

[43]Weisenberger, D.J., Campan, M., Long, T.I., Kim, M., Woods, C., Fiala, E., Ehrlich, M., Laird, P.W., 2005. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res., 33(21):6823-6836.

[44]Wilson, M.J., Shivapurkar, N., Poirier, L.A., 1984. Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet. Biochem. J., 218(3):987-990.

[45]Wolff, E.M., Byun, H.M., Han, H.F., Sharma, S., Nichols, P.W., Siegmund, K.D., Yang, A.S., Jones, P.A., Liang, G., 2010. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet., 6(4):e1000917.

[46]Yang, A.S., Estecio, M.R., Doshi, K., Kondo, Y., Tajara, E.H., Issa, J.P., 2004. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res., 32(3):e38.

[47]Zhu, Z.Z., Sparrow, D., Hou, L., Tarantini, L., Bollati, V., Litonjua, A.A., Zanobetti, A., Vokonas, P., Wright, R.O., Baccarelli, A., et al., 2011. Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: the normative aging study. Cancer Causes Control, 22(3):437-447.